Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

Articles published in
Curr Opin Obstet Gynecol
    February 2021
  1. WASHINGTON CR, Moore KN
    PARP inhibitors in the treatment of ovarian cancer: a review.
    Curr Opin Obstet Gynecol. 2021;33:1-6.
    >> Share

    December 2019
  2. WALSH CS
    Latest clinical evidence of maintenance therapy in ovarian cancer.
    Curr Opin Obstet Gynecol. 2019 Dec 10. doi: 10.1097/GCO.0000000000000592.
    >> Share

  3. KUBALANZA K, Konecny GE
    Mechanisms of PARP inhibitor resistance in ovarian cancer.
    Curr Opin Obstet Gynecol. 2019 Dec 6. doi: 10.1097/GCO.0000000000000600.
    >> Share

    February 2019
  4. MCCANN KE
    Poly-ADP-ribosyl-polymerase inhibitor resistance mechanisms and their therapeutic implications.
    Curr Opin Obstet Gynecol. 2019;31:12-17.
    >> Share

    December 2018
  5. STEWART D, Cristea M
    Antibody-drug conjugates for ovarian cancer: current clinical development.
    Curr Opin Obstet Gynecol. 2018 Dec 10. doi: 10.1097/GCO.0000000000000515.
    >> Share

    November 2018
  6. WINTERHOFF B, Talukdar S, Chang Z, Wang J, et al
    Single-cell sequencing in ovarian cancer: a new frontier in precision medicine.
    Curr Opin Obstet Gynecol. 2018 Nov 30. doi: 10.1097/GCO.0000000000000516.
    >> Share

  7. WASHINGTON C, Gunderson CC, Moore KN
    Update in the use and evaluation of poly (ADP-ribose) polymerase inhibitors in epithelial ovarian cancer: current and pending clinical research.
    Curr Opin Obstet Gynecol. 2018 Nov 15. doi: 10.1097/GCO.0000000000000507.
    >> Share

    February 2018
  8. MCCANN KE
    Novel poly-ADP-ribose polymerase inhibitor combination strategies in ovarian cancer.
    Curr Opin Obstet Gynecol. 2018;30:7-16.
    >> Share

  9. VOLPE J, Filipi JG, Cooper OR, Penson RT, et al
    Frontline therapy of ovarian cancer: trials and tribulations.
    Curr Opin Obstet Gynecol. 2018;30:1-6.
    >> Share

    November 2017
  10. PALEARI L, DeCensi A
    Endocrine therapy in ovarian cancer: where do we stand?
    Curr Opin Obstet Gynecol. 2017 Nov 14. doi: 10.1097/GCO.0000000000000423.
    >> Share

    November 2016
  11. KROEGER PT JR, Drapkin R
    Pathogenesis and heterogeneity of ovarian cancer.
    Curr Opin Obstet Gynecol. 2016.
    >> Share

    February 2016
  12. WALSH CS, Hodeib M
    Leveraging DNA repair deficiency in gynecologic oncology.
    Curr Opin Obstet Gynecol. 2016;28:24-31.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016